Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-12-02

Clinical Trial Update: The Utility of PSADv (PSA Density Velocity) While on Dutasteride for Predicting Prostate Cancer Incidence and Grade and Stage

View source ↗

Summary

This clinical trial update investigates whether PSA density velocity while taking dutasteride can predict prostate cancer incidence and the tumor grade and stag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DUTASTERIDE (Dutasteride)

Snippet

Sponsor: University Urological Associates Inc. | Conditions: Prostate Cancer | Status: UNKNOWN